Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Endocrinology
•
Bone and Calcium Disorders
Is there a target alkaline phosphatase level for hypophosphatasia patients on asfotase alfa therapy?
Answer from: at Academic Institution
The package insert states, “do not rely on serum alkaline phosphatase measurements for clinical decision making in patients treated with Strensiq”.
Sign In
or
Register
to read more
29136
Related Questions
Would you start romosozumab in an active smoker?
Do you recommend initiating zoledronic acid for osteoporosis at the time of hospitalization for a fracture?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
Would you consider the use of romosozumab in men who have failed therapy with teriparatide and sustained multiple vertebral fractures?
Do you use bone turnover markers to assess medical adherence in patients treated for osteoporosis?
Is there a maximum duration for raloxifene use?
In a patient with a history of parathyroidectomy (due to primary hyperparathyroidism) with low T- scores and high risk of fractures, is there any contraindication to give teriparatide/Forteo if PTH is in normal range after surgery?
Would you use a parathyroid hormone analog for treatment of osteoporosis in a patient with mildly elevated AlkPhos of unclear etiology?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
Is Evenity appropriate for a patient with severe osteoporosis (T-score -3.1) unresponsive to bisphosphonates and persistent primary hyperparathyroidism despite two surgeries?